For liposomal drugs, the lamellarity, i.e. the number of membrane layers within a liposomal particle, can reflect the efficiency of the liposomal drug product. The lamellarity assessment is one of the physiochemical properties required by authorities for the release of drug products.
TEM enables a direct visualization of each individual particle and represents the perfect tool for an objective assessment of the lamellarity level of a product.
At QuTEM, we offer lamellarity analysis of liposomal drugs using our proprietary software. First, we analyze the TEM images by detecting particles present on the images, after which a qualified scientist classifies the particles until the statistically relevant amount of data is collected. The results are then compiled in a report with example images and particle statistics.
At QuTEM, the lamellarity assessment is typically performed for the following particle types:
Our analysis workflow includes: